Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) has a market capitalization of $352.6M and trades at $10.52. The 52-week range is 10.02-10.52.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -187.9, Earnings Per Share (EPS) of $-0.06.
The stock has a beta of 0.00, operates in the Financial Services sector.
